Nicole Hardy The FDA's move to examine the new safety data more closely makes sense, though it will likely delay any benefits for those counting on the combination therapy.
Priya Raman BRICS already covers half the world's people and a big share of trade, so stressing seafarer safety alongside economic ties shows real leadership on key issues.